Main

type

5 (blog/news article)

status

21 (imported old-v2, waiting for another import)

review version

0

cleanup version

0

pending deletion

0 (-)

created at

2025-11-30 13:51:23

updated at

2025-11-30 13:51:23

Address

url

https://eupraxiapharma.com/news/news-details/2024/Eupraxia-Pharmaceuticals-Initiates-Phase-3-Development-Program-for-EP-104IAR/default.aspx

url length

139

url crc

43132

url crc32

1699391612

location type

1 (url matches target location, page_location is empty)

canonical status

2 (missing canonical tag in html)

canonical page id

-

Source

domain id

133553095

domain tld

2211

domain parts

0

originating warc id

-

originating url

https://data.commoncrawl.org/crawl-data/CC-MAIN-2025-33/segments/1754151279927.26/warc/CC-MAIN-20250806232852-20250807022852-00536.warc.gz

source type

11 (CommonCrawl)

Server response

server ip

162.159.129.11

Publication date

2025-08-07 00:31:36

Fetch attempts

0

Original html size

81906

Normalized and saved size

55979

Content

title

Eupraxia Pharmaceuticals Initiates Phase 3 Development Program for EP-104IAR

excerpt

content

author

updated

1767495572

Text analysis

block type

0

extracted fields

8

extracted bits

title

detected location

0

detected language

1 (English)

category id

Medicine [en] (226)

index version

2025123101

paywall score

0

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

12676

text words

2230

text unique words

701

text lines

155

text sentences

62

text paragraphs

18

text words per sentence

35

text matched phrases

3

text matched dictionaries

5